NanoViricides Inc. (NNVC): Three of Six Conferences: Novel Vacci...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Wednesday, 07/12/2006 8:22:35 PM

Wednesday, July 12, 2006 8:22:35 PM

Three of Six Conferences:

Novel Vaccines: August 21-23
http://www.healthtech.com/2006/vac/day1.asp

Targeted Nanodelivery: Oct. 12-13
http://www.healthtech.com/2006/nno/day%202.asp

Nanobiotech World Congress: Nov 16-17
http://www.selectbiosciences.com/conferences/files/Agendas%202006/NanoBrochure20May.pdf

doc.feelgoode@yahoo.com

"It ain't what they call you, it's what you answer to." --WC Fields

Keep Last Read

Replies (2) Next 10 Prev Next

Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/15/2024 08:44:44 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/27/2024 08:15:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM

InvestorsHub NewsWire

Only $200 per official company press release!